Skip to main content
Clinical Trials/NCT01838096
NCT01838096
Unknown
N/A

Alumina Matrix Composite Ceramic Bearing Total Hip Arthroplasty in Patients Younger Than 30 Years

Seoul National University Bundang Hospital0 sites92 target enrollmentMarch 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Advanced Hip Disease
Sponsor
Seoul National University Bundang Hospital
Enrollment
92
Primary Endpoint
survival rate of 4th generation ceramic-on-ceramic THA
Last Updated
4 years ago

Overview

Brief Summary

This study will evaluate clinical outcome on patients who undergo cementless 4th generation ceramic (BIOLOX®delta, CeramTec GmbH, Plochingen, Germany) on ceramic (CoC) bearing total hip aArthroplasty ("THA") in patients younger than 30 years.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
November 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kyung-Hoi Koo

Professor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

  • younger than 30 years
  • advanced hip disease

Exclusion Criteria

  • older than 30 years

Outcomes

Primary Outcomes

survival rate of 4th generation ceramic-on-ceramic THA

Time Frame: 5 years

survival rate of 4th generation ceramic-on-ceramic THA end point for best senario ; any reoperation end point for moderate senario ; loosening end point for worst senario ; osteolysis

Similar Trials